1. Home
  2. RGEN vs CCCS Comparison

RGEN vs CCCS Comparison

Compare RGEN & CCCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CCCS
  • Stock Information
  • Founded
  • RGEN 1981
  • CCCS 1980
  • Country
  • RGEN United States
  • CCCS United States
  • Employees
  • RGEN N/A
  • CCCS N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CCCS Computer Software: Prepackaged Software
  • Sector
  • RGEN Health Care
  • CCCS Technology
  • Exchange
  • RGEN Nasdaq
  • CCCS Nasdaq
  • Market Cap
  • RGEN 6.6B
  • CCCS 5.8B
  • IPO Year
  • RGEN N/A
  • CCCS N/A
  • Fundamental
  • Price
  • RGEN $124.35
  • CCCS $9.71
  • Analyst Decision
  • RGEN Buy
  • CCCS Buy
  • Analyst Count
  • RGEN 9
  • CCCS 8
  • Target Price
  • RGEN $167.38
  • CCCS $11.88
  • AVG Volume (30 Days)
  • RGEN 1.0M
  • CCCS 7.8M
  • Earning Date
  • RGEN 07-29-2025
  • CCCS 07-31-2025
  • Dividend Yield
  • RGEN N/A
  • CCCS N/A
  • EPS Growth
  • RGEN N/A
  • CCCS N/A
  • EPS
  • RGEN N/A
  • CCCS 0.00
  • Revenue
  • RGEN $673,956,000.00
  • CCCS $996,961,000.00
  • Revenue This Year
  • RGEN $14.14
  • CCCS $13.36
  • Revenue Next Year
  • RGEN $14.32
  • CCCS $9.15
  • P/E Ratio
  • RGEN N/A
  • CCCS $32,350.00
  • Revenue Growth
  • RGEN 8.73
  • CCCS 9.60
  • 52 Week Low
  • RGEN $102.97
  • CCCS $8.14
  • 52 Week High
  • RGEN $182.52
  • CCCS $12.88
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 54.96
  • CCCS 52.34
  • Support Level
  • RGEN $111.15
  • CCCS $9.14
  • Resistance Level
  • RGEN $127.57
  • CCCS $9.72
  • Average True Range (ATR)
  • RGEN 4.80
  • CCCS 0.32
  • MACD
  • RGEN 1.31
  • CCCS -0.03
  • Stochastic Oscillator
  • RGEN 63.23
  • CCCS 41.91

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CCCS CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. It operates in a single segment being Domestic segment which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in United States and China. Majority of the revenue is generated from United States.

Share on Social Networks: